U.S. flag

An official website of the United States government

NM_000295.5(SERPINA1):c.761A>G (p.Gln254Arg) AND Alpha-1-antitrypsin deficiency

Germline classification:
Likely benign (1 submission)
Last evaluated:
Nov 2, 2017
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000768539.1

Allele description [Variation Report for NM_000295.5(SERPINA1):c.761A>G (p.Gln254Arg)]

NM_000295.5(SERPINA1):c.761A>G (p.Gln254Arg)

Gene:
SERPINA1:serpin family A member 1 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
14q32.13
Genomic location:
Preferred name:
NM_000295.5(SERPINA1):c.761A>G (p.Gln254Arg)
HGVS:
  • NC_000014.9:g.94381027T>C
  • NG_008290.1:g.14666A>G
  • NM_000295.5:c.761A>GMANE SELECT
  • NM_001002235.3:c.761A>G
  • NM_001002236.3:c.761A>G
  • NM_001127700.2:c.761A>G
  • NM_001127701.2:c.761A>G
  • NM_001127702.2:c.761A>G
  • NM_001127703.2:c.761A>G
  • NM_001127704.2:c.761A>G
  • NM_001127705.2:c.761A>G
  • NM_001127706.2:c.761A>G
  • NM_001127707.2:c.761A>G
  • NP_000286.3:p.Gln254Arg
  • NP_001002235.1:p.Gln254Arg
  • NP_001002236.1:p.Gln254Arg
  • NP_001121172.1:p.Gln254Arg
  • NP_001121173.1:p.Gln254Arg
  • NP_001121174.1:p.Gln254Arg
  • NP_001121175.1:p.Gln254Arg
  • NP_001121176.1:p.Gln254Arg
  • NP_001121177.1:p.Gln254Arg
  • NP_001121178.1:p.Gln254Arg
  • NP_001121179.1:p.Gln254Arg
  • LRG_575t1:c.761A>G
  • LRG_575:g.14666A>G
  • LRG_575p1:p.Gln254Arg
  • NC_000014.8:g.94847364T>C
Protein change:
Q254R
Links:
dbSNP: rs1566753789
NCBI 1000 Genomes Browser:
rs1566753789
Molecular consequence:
  • NM_000295.5:c.761A>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001002235.3:c.761A>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001002236.3:c.761A>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001127700.2:c.761A>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001127701.2:c.761A>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001127702.2:c.761A>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001127703.2:c.761A>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001127704.2:c.761A>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001127705.2:c.761A>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001127706.2:c.761A>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001127707.2:c.761A>G - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Alpha-1-antitrypsin deficiency (A1ATD)
Synonyms:
AAT deficiency; A1AT deficiency; Alpha1-Antitrypsin Deficiency
Identifiers:
MONDO: MONDO:0013282; MedGen: C0221757; Orphanet: 60; OMIM: 613490

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000899239HerediLab, Inc.
criteria provided, single submitter

(HerediLab_Assertion_Criteria)
Likely benign
(Nov 2, 2017)
germlineclinical testing

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyesnot providednot providednot providednot providednot providedclinical testing

Details of each submission

From HerediLab, Inc., SCV000899239.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Apr 23, 2022